INS and Hypoglycemia: The commercial MiniMed 640G system was assessed in a single-arm outpatient study [29], a single-arm inpatient study with nocturnal hypoglycemia induced by increased insulin delivery [35], and a randomized controlled trial conducted in children and adolescents [42].